发明名称 Granulysin in immunotherapy
摘要 Methods of stimulating or enhancing an immune response in a host are disclosed. The methods include contacting a monocyte with 15 kD granulysin thereby producing a monocyte-derived dendritic cell. In one example, the method further includes contacting the monocyte or monocyte-derived dendritic cell with a target antigen, such as a tumor antigen or an autoimmune antigen. In another embodiment, the method includes contacting the monocyte with an additional agent that enhances maturation of dendritic cells or induces immunological tolerance. The methods are of use in vivo, in vitro and ex vivo. In another aspect, the disclosure relates to compositions and methods for the treatment of tumors.
申请公布号 US8815229(B2) 申请公布日期 2014.08.26
申请号 US201013501726 申请日期 2010.10.08
申请人 The United States of America, as represented by the Secretary, Department of Health and Human Services 发明人 Krensky Alan M.;Clayberger Carol
分类号 A61K38/17;C07K14/705 主分类号 A61K38/17
代理机构 Klarquist Sparkman, LLP 代理人 Klarquist Sparkman, LLP
主权项 1. A method of stimulating production of a monocyte-derived dendritic cell, comprising contacting a monocyte with 15 kD granulysin, thereby producing a monocyte-derived dendritic cell.
地址 Washington DC US